Virtual Presentation

Recent Advances in the Treatment of Head and Neck Cancer

Source: Head and Neck Cancer: Key Challenges and Emerging Opportunities

Recent Advances in the Treatment of Head and Neck Cancer

Faculty:

Corey J. Langer, MD, FACP

CREDIT INFORMATION

Release Date: March 02, 2010

Expiration Date: March 01, 2011

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Employ the TNM staging system for head and neck cancers when determining prognosis and treatment for newly diagnosed patients
Compare different strategies for integrating chemotherapy and radiation protocols in patients with locoregionally advanced head and neck cancer
Evaluate the role of cetuximab in treating patients with newly diagnosed locoregionally advanced or recurrent/metastatic head and neck cancer
Discuss human papillomavirus status as a predictor of survival outcome among patients with head and neck cancer

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.